4//SEC Filing
Griffin Noreen 4
Accession 0001213900-21-031071
CIK 0001559356other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 8:49 PM ET
Size
14.5 KB
Accession
0001213900-21-031071
Insider Transaction Report
Form 4
Griffin Noreen
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Other
Common Stock
2021-05-28+0→ 429 total - Other
Common Stock
2021-05-28+0→ 704 total(indirect: By: Griffin Enterprises Group, Inc.) - Other
Warrants (Right to Buy)
2021-05-28+0→ 7,420 totalExercise: $5.00From: 2017-06-30Exp: 2032-06-26→ Common Stock (7,420 underlying) - Other
Common Stock
2021-05-28+0→ 2,685 total(indirect: By Trust) - Other
Convertible Note
2021-05-28+0→ 49,772 total(indirect: By: Global Reverb Corporation)Exercise: $5.00From: 2017-06-30Exp: 2032-06-26→ Common Stock (49,772 underlying)
Footnotes (4)
- [F1]The Reporting Person may be deemed to have entered into a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, as of May 28, 2021 in connection with the Reporting Person and the Issuer's execution of a non-binding Term Sheet as of this date in which the Reporting Person executed such Term Sheet as representative of certain other parties to the Term Sheet. The Reporting Person disclaims the existence of a "group" and disclaims beneficial ownership of any securities held by such "group" (and this report shall not be deemed an admission that any such person is the beneficial owner of any such securities), except to the extent of her pecuniary interest, if any, in such securities.
- [F2]50% owned by the Reporting Person and 50% owned and managed by Robert Wilson, who is the Reporting Person's son, and the Reporting Person has shared voting and dispositive power over such shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, and the inclusion of these shares in this Form 4 shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 13 or for any other purpose.
- [F3]An irrevocable trust for the benefit of the Reporting Person's children and grandchildren, and the Reporting Person has shared voting and dispositive power over such shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, and the inclusion of these shares in this Form 4 shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 13 or for any other purpose.
- [F4]A Florida corporation, of which Griffin is the sole officer, director and shareholder, and Griffin has sole voting and dispositive power over its securities.
Documents
Issuer
Immune Therapeutics, Inc.
CIK 0001559356
Entity typeother
Related Parties
1- filerCIK 0001611517
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 8:49 PM ET
- Size
- 14.5 KB